Skip to content

Yangxue Qingluo Mingmu Decoction for the Treatment of High Myopia Caused by Deficiency Fire and Collateral Damage Clinical study of macular hemorrhage

Yangxue Qingluo Mingmu Decoction for the Treatment of High Myopia Caused by Deficiency Fire and Collateral Damage Clinical study of macular hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000012
Enrollment
Unknown
Registered
2023-05-26
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular hemorrhage in high myopia

Interventions

Group with choroidal neovascularization:Oral Yangxue Qingluo Mingmu Decoction
Group without choroidal neovascularization:Oral Yangxue Qingluo Mingmu Decoction

Sponsors

Eye Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criteria of Western medicine: According to the "Complete Book of Ophthalmology", the general diagnostic criteria for refractive errors in China: ? diopter > -6.00D; ? Fundus examination: fundus changes in high myopia with patchy hemorrhage in the macular region. Diagnostic criteria of traditional Chinese medicine: According to the "Criteria for the Diagnosis and Curative Effect of Diseases and Signs in Traditional Chinese Medicine" and "Clinical Diagnosis and Treatment Terminology of Traditional Chinese Medicine - Syndrome Part", it conforms to the (ophthalmology) syndrome of yin deficiency of liver and kidney, deficiency of fire and collateral damage. Main symptoms: blurred vision, macular hemorrhage, dizziness, dry throat, and astringent eyes. Secondary symptoms: restlessness, insomnia, sore waist and knees, and nocturnal sweating. 2.Fundus examination: fundus changes in high myopia with patchy hemorrhage in the macular region 3.Age: 20-60 years old 4. The patient signs the informed consent form

Exclusion criteria

Exclusion criteria: 1.Cases that do not meet the above diagnostic criteria 2. Age>60 3. Exclude other eye diseases, such as age related macular degeneration, fundus vascular striae, central exudative retinopathy, retinal vein occlusion, retinal vasculitis, etc 4. Exclude systemic diseases with other eye damage, such as hypertensive retinopathy, diabetes retinopathy, etc

Design outcomes

Primary

MeasureTime frame
Thickness and volume of macular fovea;vision;

Secondary

MeasureTime frame
Traditional Chinese Medicine Symptoms;

Countries

China

Contacts

Public Contacthong-Zhang

Eye Hospital,China Academy of Chinese Medical Sciences

zhanghong_zhbj@sina.com18611240360

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026